{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:29:34Z","timestamp":1791833374035,"version":"4.3.4"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>There are racial and ethnic disparities in opioid use disorder (OUD) treatment engagement during and after emergency department (ED) encounters.<\/jats:p><\/jats:sec>Objective<\/jats:title>To identify patterns of barriers and facilitators to treatment engagement after an ED visit among Black, Hispanic, and White individuals with OUD.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This qualitative study was conducted from June 2023 to May 2024 using in-depth semistructured individual telephone interviews. Participants with OUD were previously enrolled in a multisite study comparing 2 formulations of buprenorphine in ED patients with untreated OUD on treatment engagement.<\/jats:p><\/jats:sec>Exposures<\/jats:title>A diagnosis of moderate-to-severe OUD and a visit to an ED.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was identification of key themes at both the behavioral and health system levels associated with treatment engagement, identified through thematic analysis of interview data.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 57 individuals (20 female [35.1%]; mean [SD] age, 41.7 [12.8] years; 20 Black [35.1%]; 17 Hispanic [29.8%]; 20 White [35.1%]) participated in the study. Although racial and ethnic group-specific factors existed, common barriers to treatment engagement included stigma, structural factors (eg, transportation and insurance), uncertainty navigating the health system, and mental health issues. Black participants specifically described how previous trauma and daily stress contributed to a lack of treatment engagement. Black and Hispanic participants expressed experiences of racism and mistrust within the health system. Hispanic and White participants expressed concerns about the adverse effects and taste of sublingual buprenorphine. Common facilitators included positive attitudes toward treatment and patient experiences with ED staff and stable health care access. Hispanic participants described family support as a crucial factor toward treatment engagement. Black participants expressed the importance of connecting with individuals who were abstinent.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this qualitative study of 57 individuals with OUD previously treated in the ED, common themes emerged across racial and ethnic groups. However, Black, Hispanic, and White individuals with OUD encountered distinct barriers and facilitators to treatment engagement after an ED visit, such as the importance of family support among Hispanic individuals as a facilitator and experiences of racism within the health system among both Black and Hispanic individuals as a barrier. Future ED-based interventions should address disparities by reducing barriers and enhancing facilitators to improve equitable treatment access.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.20661","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:00:43Z","timestamp":1752505243000},"page":"e2520661","source":"Crossref","is-referenced-by-count":6,"title":["Racial and Ethnic Factors and Opioid Use Disorder Treatment After an Emergency Department Visit"],"prefix":"10.1001","volume":"8","author":[{"suffix":"Jr","given":"Edouard","family":"Coupet","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek C.","family":"Chawarski","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavari","family":"Hercules","sequence":"additional","affiliation":[{"name":"Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Williams","sequence":"additional","affiliation":[{"name":"Kansas City University College of Osteopathic Medicine, Kansas City, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Murphy Ward","sequence":"additional","affiliation":[{"name":"Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia H.","family":"Owens","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn F.","family":"Hawk","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shara H.","family":"Martel","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"D\u2019Onofrio","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"issue":"5","key":"zoi250628r2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1176\/appi.ajp.20230917","article-title":"Understanding and addressing widening racial inequalities in drug overdose.","volume":"181","author":"Friedman","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"9","key":"zoi250628r3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S2215-0366(23)00119-0","article-title":"Increasing overdose deaths among Black Americans: a review of the literature.","volume":"10","author":"Gibbons","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"zoi250628r4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"issue":"19","key":"zoi250628r5","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMsa2212412","article-title":"Racial inequality in receipt of medications for opioid use disorder.","volume":"388","author":"Barnett","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi250628r6","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s11920-024-01556-7","article-title":"Addressing racial and ethnic inequities in opioid overdose mortality: strategies for equitable interventions and structural change.","volume":"26","author":"Cruz","year":"2024","journal-title":"Curr Psychiatry Rep"},{"issue":"16","key":"zoi250628r7","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial.","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"issue":"10","key":"zoi250628r8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.21209","article-title":"Trends in the use of buprenorphine in US emergency departments, 2002-2017.","volume":"3","author":"Rhee","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi250628r9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.44955","article-title":"Perspectives about emergency department care encounters among adults with opioid use disorder.","volume":"5","author":"Hawk","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi250628r10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/acem.14197","article-title":"A qualitative study of emergency department patients who survived an opioid overdose: perspectives on treatment and unmet needs.","volume":"28","author":"Hawk","year":"2021","journal-title":"Acad Emerg Med"},{"issue":"2","key":"zoi250628r11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282215","article-title":"Emergency department experiences of people who use drugs who left or were discharged from hospital against medical advice.","volume":"18","author":"Mayer","year":"2023","journal-title":"PLoS One"},{"key":"zoi250628r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108428","article-title":"Emergency department patients with untreated opioid use disorder: a comparison of those seeking versus not seeking referral to substance use treatment.","volume":"219","author":"Coupet","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"zoi250628r13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.5852","article-title":"Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients.","volume":"3","author":"Kilaru","year":"2020","journal-title":"JAMA Netw Open"},{"key":"zoi250628r14","doi-asserted-by":"publisher","DOI":"10.1111\/acem.70035","article-title":"Racial, ethnic, and sex disparities in buprenorphine treatment from emergency departments by discharge diagnosis.","author":"Chhabra","year":"2025","journal-title":"Acad Emerg Med"},{"key":"zoi250628r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2021.106359","article-title":"The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation.","volume":"104","author":"D\u2019Onofrio","year":"2021","journal-title":"Contemp Clin Trials"},{"issue":"9","key":"zoi250628r18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations.","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"issue":"S1","key":"zoi250628r19","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.2105\/AJPH.2018.304883","article-title":"The National Institute on Minority Health and Health Disparities research framework.","volume":"109","author":"Alvidrez","year":"2019","journal-title":"Am J Public Health"},{"issue":"9","key":"zoi250628r20","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1080\/08870446.2011.613995","article-title":"The theory of planned behaviour: reactions and reflections.","volume":"26","author":"Ajzen","year":"2011","journal-title":"Psychol Health"},{"issue":"5","key":"zoi250628r21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","article-title":"Purposeful sampling for qualitative data collection and analysis in mixed method implementation research.","volume":"42","author":"Palinkas","year":"2015","journal-title":"Adm Policy Ment Health"},{"issue":"4","key":"zoi250628r22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.2307\/798843","article-title":"The constant comparative method of qualitative analysis.","volume":"12","author":"Glaser","year":"1965","journal-title":"Soc Probl"},{"issue":"7","key":"zoi250628r24","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2105\/AJPH.2012.300750","article-title":"The problem with the phrase women and minorities: intersectionality\u2014an important theoretical framework for public health.","volume":"102","author":"Bowleg","year":"2012","journal-title":"Am J Public Health"},{"key":"zoi250628r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108551","article-title":"Experiences of racial discrimination in the medical setting and associations with medical mistrust and expectations of care among black patients seeking addiction treatment.","volume":"133","author":"Hall","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"zoi250628r26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228755","article-title":"Interaction effects in the association between methadone maintenance therapy and experiences of racial discrimination in U.S. healthcare settings.","volume":"15","author":"Pro","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"zoi250628r27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1353\/hpu.2024.a919810","article-title":"Experiences of stigma and discrimination compounded by intersecting identities among individuals receiving medication for opioid use disorder.","volume":"35","author":"Nwanaji-Enwerem","year":"2024","journal-title":"J Health Care Poor Underserved"},{"key":"zoi250628r28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108918","article-title":"A qualitative analysis of barriers to opioid agonist treatment for racial\/ethnic minoritized populations.","volume":"144","author":"Husain","year":"2023","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"zoi250628r29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/MLR.0000000000000638","article-title":"Perceived discrimination in health care and mental health\/substance abuse treatment among Blacks, Latinos, and Whites.","volume":"55","author":"Mays","year":"2017","journal-title":"Med Care"},{"issue":"S1","key":"zoi250628r30","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.2105\/AJPH.2022.307037","article-title":"Persistent criminalization and structural racism in US drug policy: the case of overdose Good Samaritan laws.","volume":"113","author":"Pamplin","year":"2023","journal-title":"Am J Public Health"},{"key":"zoi250628r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108867","article-title":"Racial disparities in criminal legal system involvement among New York City overdose decedents: implications for diversion programs.","volume":"226","author":"Mantha","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"zoi250628r32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108721","article-title":"\u201cIn their mind, they always felt less than\u201d: The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention.","volume":"138","author":"Anvari","year":"2022","journal-title":"J Subst Abuse Treat"},{"key":"zoi250628r33","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109405","article-title":"Factors supporting substance use improvement for Black Americans: a population health observational study.","volume":"234","author":"Sahker","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"zoi250628r34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108367","article-title":"The role of social network support in treatment outcomes for medication for opioid use disorder: a systematic review.","volume":"127","author":"Kumar","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"zoi250628r35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2018.08.004","article-title":"Understanding barriers to specialty substance abuse treatment among Latinos.","volume":"94","author":"Pinedo","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"zoi250628r36","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108649","article-title":"Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder.","volume":"221","author":"Nayak","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"zoi250628r37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/10410236.2023.2167588","article-title":"Stigma communication surrounding nonmedical opioid use among affected family members.","volume":"39","author":"Pasman","year":"2024","journal-title":"Health Commun"},{"issue":"3","key":"zoi250628r38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.annemergmed.2022.09.025","article-title":"Effectiveness of substance use navigation for emergency department patients with substance use disorders: an implementation study.","volume":"81","author":"Anderson","year":"2023","journal-title":"Ann Emerg Med"},{"key":"zoi250628r39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108837","article-title":"Emergency department interventions for opioid use disorder: a synthesis of emerging models.","volume":"141","author":"Thomas","year":"2022","journal-title":"J Subst Abuse Treat"},{"key":"zoi250628r17","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"zoi250628r1","doi-asserted-by":"crossref","unstructured":"Garnett? MF, Mini\u00f1o? AM. Drug overdose deaths in the United States, 2003-2023. Centers for Disease Control and Prevention. December 19, 2024. Accessed June 4, 2025. https:\/\/stacks.cdc.gov\/view\/cdc\/170565","DOI":"10.15620\/cdc\/170565"},{"key":"zoi250628r16","unstructured":"Mee-Lee? D, Shulman? GD, Fishman? MJ, Gastfriend? DR, Miller? MM. The ASAM criteria: treatment criteria for addictive, substance-related, and co-occurring conditions. American Society of Addiction Medicine. 2013. Accessed June 4, 2025. https:\/\/www.americanhealthholding.com\/Content\/Pdfs\/asam%20criteria.pdf"},{"key":"zoi250628r23","unstructured":"SocioCultural Research Consultants. Dedoose version 9.0.17: web application for managing, analyzing, and presenting qualitative and mixed method research. 2021. Accessed June 4, 2025. www.dedoose.com"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2836400\/coupet_2025_oi_250628_1751908618.14529.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:00:45Z","timestamp":1752505245000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2836400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.20661","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]}}}